Found: 20
Select item for more details and to access through your institution.
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the KRAS (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 3, p. 130, doi. 10.3390/jpm10030130
- By:
- Publication type:
- Article
Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6559, doi. 10.3390/ijms23126559
- By:
- Publication type:
- Article
HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2271, doi. 10.3390/ijms20092271
- By:
- Publication type:
- Article
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 4, p. 643, doi. 10.3390/biom10040643
- By:
- Publication type:
- Article
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 9, p. 467, doi. 10.3390/biom9090467
- By:
- Publication type:
- Article
High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1620, doi. 10.3390/cancers13071620
- By:
- Publication type:
- Article
ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1399, doi. 10.3390/cancers12061399
- By:
- Publication type:
- Article
Repositioning VU‐0365114 as a novel microtubule‐destabilizing agent for treating cancer and overcoming drug resistance.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 386, doi. 10.1002/1878-0261.13536
- By:
- Publication type:
- Article
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.764912
- By:
- Publication type:
- Article
Sudden-Onset Pancytopenia with Intracranial Hemorrhage after Oxaliplatin Treatment: A Case Report and Literature Review.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 125, doi. 10.1093/jjco/hyq162
- By:
- Publication type:
- Article
Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer: A retrospective cohort study in Taiwan.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 1107, doi. 10.1002/ijc.32841
- By:
- Publication type:
- Article
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 13, p. 2296, doi. 10.3390/diagnostics13132296
- By:
- Publication type:
- Article
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 616, doi. 10.3390/cells13070616
- By:
- Publication type:
- Article
Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma.
- Published in:
- Journal of Surgical Oncology, 2011, v. 103, n. 8, p. 773, doi. 10.1002/jso.21852
- By:
- Publication type:
- Article
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.
- Published in:
- Oncology Letters, 2023, v. 26, n. 6, p. N.PAG, doi. 10.3892/ol.2023.14120
- By:
- Publication type:
- Article
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma.
- Published in:
- Genes, 2019, v. 10, n. 10, p. 766, doi. 10.3390/genes10100766
- By:
- Publication type:
- Article
Epidermal growth factor receptor R521 K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 791, doi. 10.1111/j.1349-7006.2012.02225.x
- By:
- Publication type:
- Article
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43006-z
- By:
- Publication type:
- Article
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43006-z
- By:
- Publication type:
- Article
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
- Published in:
- Nutrients, 2023, v. 15, n. 13, p. 2971, doi. 10.3390/nu15132971
- By:
- Publication type:
- Article